Kara Elam,  —

Kara Elam is currently working on her Doctorate in Health Policy. She holds Master Degrees in both epidemiology and microbiology. Her research interests include emerging viral diseases, the intersection of human rights and intellectual property rights, and ending violence against women.

Articles by Kara Elam

Review Study Highlights Burkholderia Pseudomallei Infection in Cystic Fibrosis Around the World

Researchers from the University of Queensland (UQ), Australia, have recently released findings from their scientific literature review in an effort to identify all cases of Burkholderia pseudomallei infections in cystic fibrosis (CF) patients globally, the potential risk factors for acquisition, clinical consequences, and optimal treatment strategies. The findings entitled, “An international,…

Another Study Reveals Positive Results in Fighting P. Aeruginosa

AmpliPhi BioSciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced study results for a trial looking at a novel treatment strategy for cystic fibrosis (CF) patients. The results, which suggested that bacteriophages remain active against Pseudomonas aeruginosa (P. aeruginosa)…

Preventing Exacerbation in CF Patients Focus of Promising New Study

An article published in BioMed Central’s Pulmonary Medicine journal provides evidence that the impaired immune system, a key feature in cystic fibrosis (CF), may lead to patients being deprived of necessary oxygen due to lung tissue destruction. The study, entitled “Hypoxia down-regulates expression…

Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.